Administration of a non-selective muscarinic receptor inhibitor, atropine, suppressed SNU-C4 colon cancer cell migration; however, H508 colon cancer cell migration requires the activation of matrix metalloproteinase 7 [50, 53]. Here, MMP7 is linked to malignant colon neoplasm.